Streptolysin O Rapidly Impairs Neutrophil Oxidative Burst and Antibacterial Responses to Group A Streptococcus
Overview
Authors
Affiliations
Group A Streptococcus (GAS) causes a wide range of human infections, ranging from simple pharyngitis to life-threatening necrotizing fasciitis and toxic shock syndrome. A globally disseminated clone of M1T1 GAS has been associated with an increase in severe, invasive GAS infections in recent decades. The secreted GAS pore-forming toxin streptolysin O (SLO), which induces eukaryotic cell lysis in a cholesterol-dependent manner, is highly upregulated in the GAS M1T1 clone during bloodstream dissemination. SLO is known to promote GAS resistance to phagocytic clearance by neutrophils, a critical first element of host defense against invasive bacterial infection. Here, we examine the role of SLO in modulating specific neutrophil functions during their early interaction with GAS. We find that SLO at subcytotoxic concentrations and early time points is necessary and sufficient to suppress neutrophil oxidative burst, in a manner reversed by free cholesterol and anti-SLO blocking antibodies. In addition, SLO at subcytotoxic concentrations blocked neutrophil degranulation, interleukin-8 secretion and responsiveness, and elaboration of DNA-based neutrophil extracellular traps, cumulatively supporting a key role for SLO in GAS resistance to immediate neutrophil killing. A non-toxic SLO derivate elicits protective immunity against lethal GAS challenge in a murine infection model. We conclude that SLO exerts a novel cytotoxic-independent function at early stages of invasive infections (<30 min), contributing to GAS escape from neutrophil clearance.
Zawrotniak M, Satala D, Juszczak M, Bras G, Rapala-Kozik M Sci Rep. 2025; 15(1):6946.
PMID: 40011643 PMC: 11865311. DOI: 10.1038/s41598-025-91425-x.
Akaishi T Cureus. 2025; 17(2):e78863.
PMID: 39936085 PMC: 11813535. DOI: 10.7759/cureus.78863.
Streptolysin O accelerates the conversion of plasminogen to plasmin.
Tang D, Khakzad H, Hjortswang E, Malmstrom L, Ekstrom S, Happonen L Nat Commun. 2024; 15(1):10212.
PMID: 39587097 PMC: 11589678. DOI: 10.1038/s41467-024-54173-6.
Gao N, Uchiyama S, Pill L, Dahesh S, Olson J, Bautista L Infect Microbes Dis. 2024; 3(2):87-100.
PMID: 39450141 PMC: 11501091. DOI: 10.1097/im9.0000000000000044.
The intricate pathogenicity of Group A : A comprehensive update.
Bergsten H, Nizet V Virulence. 2024; 15(1):2412745.
PMID: 39370779 PMC: 11542602. DOI: 10.1080/21505594.2024.2412745.